NCT00002759View on ClinicalTrials.gov

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 30, 1996

Primary Completion Date

April 30, 2002

Conditions
Drug/Agent Toxicity by Tissue/OrganLymphomaNeutropeniaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cyclosporine

DRUG

irinotecan hydrochloride

DRUG

phenobarbital

Trial Locations (1)

60637-1470

University of Chicago Cancer Research Center, Chicago

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00002759 - Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter